肺炎克雷伯菌

医院感染肺炎克雷伯菌的染色体和质粒DNA指纹图分析

Rep-PCR and plasmid profile analysis for typing Klebsiella pneumoniae strains

对产ESBLs肺炎克雷伯菌经验性抗生素治疗失败为CAP死亡的主要原因之一。

Most dead cases with CAP by ESBLs-producing Klebsiella pneumoniae were ascribed to empirical antibiotic therapy failure .

肺炎克雷伯菌随机DNA多态性分型研究

Typing of Klebsiella pneumoniae Strains by Random Amplification of Polymorphic DNA

肺炎克雷伯菌随机扩增多态性DNA的分子流行病学研究

Molecular Epidemiological Study of Klebsiella pneumoniae by Randomly Amplified Polymorphic DNA Analysis

方法用双纸片扩散法和Etest筛选肺炎克雷伯菌ESBLs；

Methods ESBLs of Klebsiella were screened by double disk diffusion test and E test .

亚胺培南诱导生物被膜肺炎克雷伯菌（C组）超广谱β-内酰胺酶的检出率为65.0%（26/40）。

The isolation rate of ESBLs producting strains in klebsiella biofilm being induced by imipenem were 65.0 % ( 26 / 40 ) .

前言：目的采用随机扩增多态性DNA（RAPD）基因分型方法监测肺炎克雷伯菌医院感染。

Objective To monitor the hospital infection of Klebsiella pneumoniae by randomly amplified polymorphic DNA ( RAPD ) assay .

目的建立肺炎克雷伯菌随机扩增DNA多态性分型技术，以应用于临床菌株流行病学调查。

OBJECTIVE To establish the random amplification of polymorphic DNA ( RAPD ) typing technology of Klebsiella pneumoniae strains and apply it in the epidemiology investigation .

多重PCR技术检测肺炎克雷伯菌中质粒介导的AmpC酶基因

Detection of plasmid-mediated ampC β - lactamase genes in klebsiella pneumoniae by using multiplex PCR

Ⅰ类整合子与产ESBLs肺炎克雷伯菌多重耐药关系的研究

Identification of class ⅰ integrons and multidrug resistance in ESBLs-producing Klebsiella pneumonia

大肠埃希菌与肺炎克雷伯菌产ESBLs表型与基因型分析

ESBLs Phenotype and Genotype Analysis of Klebsiella and Escherichia coli

产ESBLs大肠埃希菌和肺炎克雷伯菌儿童分离株的耐药性和基因型检测

Antimicrobial resistance and genotypes of ESBLs-producing Escherichia coli and Klebsiella pneumoniae isolates

方法对临床分离的195株肺炎克雷伯菌进行ESBLs检测并采用微量稀释法测定MIC值，判断细菌的耐药性；

Pneumoniae . METHODS To detect the resistance of 195 strains ESBLs producing K.

广州地区肺炎克雷伯菌产TEM型及SHV型β-内酰胺酶基因表型的研究

Genotype of TEM - and SHV-type beta-lactamase producing Klebsiella pneumoniae in Guangzhou area

肺炎克雷伯菌（ESBLs）氨基糖苷类修饰酶基因的研究

Study on aminoglycosides-modifying enzymes gene of extended-spectrum beta-lactamases ( ESBLs ) - producing Klebsiella pneumoniae

目的研究肺炎克雷伯菌（klebsiellapneumoniae）ATCC49790与药物外排泵有关的耐药性。

Objective To investigate the drug resistance of Klebsiella pneumoniae ATCC 49790 associated with drug efflux pumps .

产AmpC酶和ESBLs肺炎克雷伯菌的耐药性分析与耐药基因检测

Antibiotic-resistant Genotypes in AmpC and ESBLs-producing Klebsiella pneumoniae

长沙地区肺炎克雷伯菌质粒介导AmpCβ内酰胺酶的检测与分析

Prevalence of plasmid-mediated AmpC beta-lactamases in the Klebsiella pneumoniae strains isolated in Changsha

ESBLs检出率以肺炎克雷伯菌最高，其次为大肠埃希菌，分别为78.5%、77.8%。

Cloacae ESBLs detected in 78.5 % of K. pneumoniae and 77.8 % of E. coli .

医院感染产ESBLs大肠埃希菌及肺炎克雷伯菌耐药监测

Detection and Surveillance on Drug Resistance of ESBLs-producing Escherichia coli and Klebsiella pneumoniae in Nosocomial Infection

产ESBLs和AmpC酶是肺炎克雷伯菌耐药的主要原因。

Producing ESBLs and AmpC enzyme was a prominent cause of resistance in K. pneumoniae .

肺炎克雷伯菌的耐药性及PFGE电泳核型

Drug resistance and the PFGE electrophoretic karyotype of Klebsiella pneumoniae

产AmpC酶肺炎克雷伯菌的耐药性及基因型研究

A study on resistance and genotypes of AmpC beta-lactamase producing Klebsiella pneumoniae in Anhui province

结果大肠埃希菌中产ESBLs菌株占22.2%、肺炎克雷伯菌中占21.8%；

RESULTS The incidence of ESBLs was 22.2 % in E. coli and 21.8 % in K. pneumoniae .

目的了解医院产超广谱β内酰胺酶（ESBLs）大肠埃希菌（E.coli）和肺炎克雷伯菌（K.pm）流行及耐药情况，以指导临床合理用药。

Objective To determine the prevalence of strains producing extended-spectrum β - lactamases ( ESBLs ) among E. coli and K.

产ESBL菌主要为肺炎克雷伯菌和大肠埃希菌；

The bacteria producing ESBL were mainly from E. coli and K.

结果发现3株肺炎克雷伯菌产诱导型质粒介导的DHA1型AmpCβ内酰胺酶。

Results Three isolates of Klebsiella pneumoniae produced DHA-1 AmpC β - lactamases which were inducible .

结论长程住院、入住ICU等是ESBLs肺炎克雷伯菌医院获得性肺炎发生的危险因素，尤以头孢噻肟的使用是主要危险因素。

Conclusion The reasonable use of cefotaxime is an important measure to control the prevalence of ESBLs-producing strains of Klebsiella pneumoniae .

结果肺炎克雷伯菌ESBL发生率为417%。

Results The positive rate of ESBL in Kpn was 41.7 % .

目的了解本地区产超广谱β-内酰胺酶（ESBLs）肺炎克雷伯菌的耐药性及基因型分布。

Objective To understand the profile of genotype and antibiotic resistance of strains producing extended spectrum beta-lactamases ( ESBLs ) .